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Tibetan medicated-bath therapy has been applied to patients with rheumatoid arthritis for
centuries. However, the detailed action mechanism of Tibetan medicated-bath therapy on the
morphology and function of joints remains unknown. We designed our investigation to
evaluate the efficacy of Tibetan medicated-bath therapy on adjuvant arthritis (AA) of rats in
comparison with water-bath and dexamethasone administration. AA was induced by
intradermal injection of Mycobacterium butyricum suspended in sterile mineral oil. The control
animals were similarly injected with sterile vehicle. Eight days after injection, rats were treated
with fresh-water bath, Tibetan medicated-bath (40 C, 15min) or intramuscular injection with
dexamethasone for 21 consecutive days after which we evaluated the severity of arthritis
visually and microscopically and measured serum interleukin (IL)-6 and tumor necrosis factor
(TNF)-a levels. While arthritis did not significantly change after water-bath treatment, the
Tibetan medicated-bath and dexamethasone groups showed diminished joint swelling and
alleviation of, inflammatory cell infiltration and the destruction of bone and cartilage.
Serum IL-6 and TNF-a levels significantly decreased. Our results demonstrated that Tibetan
medicated-bath therapy exerted a reliable effect on rat adjuvant arthritis, which may be
involved in the inflammatory cytokines, IL-6 and TNF-a. Our data provide evidence for clinical
use of Tibetan-medicated bath therapy for arthritis patients.
Keywords: adjuvant arthritis–interleukin-6–morphology–rats–Tibetan medicated-bath
therapy–tumor necrosis factor-a
Introduction
Rheumatoid arthritis (RA) is a chronic and systemic
inflammatory disease of unknown etiology and is char-
acterized by the accumulation and proliferation of
inflammatory cells in the synovial lining, resulting in the
formation of pannus tissue, which invades and destroys
adjacent cartilage and bone. RA affects 0.5–1% of the
world’s population with more women being afflicted
than men (1). Despite optimal use of currently available
anti-rheumatic agents, most RA patients live with chronic
pain and severe functional decline because these therapies
focus primarily on preventing joint inflammation and soft
tissue swelling, but are not effective in preventing cartilage
breakdown and joint destruction associated with RA.
Recently, efforts have been focused on using the class of
drugs called biologics for treating RA. Although these
agents reduce inflammation and joint destruction, their
long-term risks and benefits are not yet clear. Because of
these and other limitations, the use of complementary and
alternative medicine (CAM) therapies, such as acupunc-
ture, medicinal herbs and bath therapy, is on the rise and
according to reports 60–90% of dissatisfied arthritis
patients are likely to seek CAM therapy (2–4).
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properly cited.Balneotherapy or spa therapy emerged as an important
European treatment modality during the 1800s (5) and is
still practiced in many countries today. Records of
clinical observations about the effects of spa therapy on
human subjects have accumulated, including RA and
osteoarthritis (5–7). Tibetan medicated-bath therapy has
been applied to patients with RA and osteomyelitis since
ancient times. The main components of Tibetan medi-
cated-bath therapy are alpine plants, which grow in the
Tibetan plateau and are considered beneficial for health.
Clinical data suggest that Tibetan medicated-bath
therapy has a positive effect on RA patients by
improving immune function (8). However, the detailed
mechanism of Tibetan medicated-bath therapy on the
morphology and function of the joints remains unknown
because of ethical restrictions on clinical research.
Adjuvant arthritis (AA) in rat has been widely used as
an experimental model that shares some features with
human RA, such as swelling, cartilage degradation and
loss of joint function (9). We evaluated Tibetan
medicated-bath therapy for AA in comparison with
water-bath and administration of adrenal cortex hor-
mone, dexamethasone.
Methods
Reagents and Drugs
Mycobacterium butyricum was obtained from Difco
Laboratories (Detroit, MI, USA). Dexamethasone was
purchased from Sigma (St Louis, MO, USA). ELISA kits
for rat interleukin (IL)-6 and tumor necrosis factor
(TNF)-a were obtained from Biosource International,
Inc. (Camarillo, CA, USA). All other reagents were of
biochemical grade. The dried extract powder of Tibetan
medicine, Ganlu-Yaoyu-Keli was kindly provided by
Arura Tibetan Medicine Group (Jinghai, China).
Rats and Experimental Design
We used 5-week-old female Sprague–Dawley rats (Japan
SLC, Inc., Hamamatsu, Japan) with an average body
weight of 157.4g. Rats were maintained under conven-
tional condition with free access to tap water and
commercial diet (CE-2, CLEA Japan). All experiments
were undertaken in accordance with the guidelines for
care and use of laboratory animals, Gifu University
Graduate School of Medicine.
Rats were randomly divided into five groups of eight
animals each: control (C), adjuvant arthritis (AA), AA
and water bath (W), AA and Tibetan medicated-bath (T)
and AA and dexamethasone (D) groups. AA was induced
by a single intradermal injection of 25mgkg
 1 heat-
inactivated M. butyricum suspended in sterile mineral oil,
at the base of the tail. Control animals were similarly
injected with sterile vehicle.
Eight days after the injection, animals of D group were
injected with dexamethasone of 0.5mgkg
 1, intramuscu-
larly once a day for 21 consecutive days. Rats of W and
T groups underwent successive bath therapy at 40 C for
15min, once a day for 21 consecutive days. The bathtub
was constant in temperature with the size of
40 25 10cm. The lower half of the rat was immersed
into fresh warm water (W) or water containing Tibetan
medicine (T). For the Tibetan medicated-bath, 2.5g of
Ganlu-Yaoyu-Keli, dry powdered Tibetan medicine was
dissolved in 10l of fresh warm water.
Visual Evaluation of Arthritis Severity
During the experimental period, body weight was
regularly measured by digital balance after adjuvant
injection. Average visual arthritis scores, indicating the
severity of arthritis, were assigned to every joint by a
single observer blinded to the group of animals as
described previously (10). Rats were scored for arthritis
using the following visual scoring system: grade 0, no
swelling or erythema; grade 1, mild swelling and
erythema or digit inflammation; grade 2, moderate
swelling and erythema confined distal to the mid-paw;
grade 3, more pronounced swelling and erythema with
extension to the ankle; grade 4, severe swelling, erythema
and joint rigidity of the ankle, foot and digits. Each limb
was graded with a score of 0–4, with a maximum possible
score of 16 for each individual rat.
IL-6 and TNF-a levels in Rat Serum
All animals were sacrificed under Nembutal anesthesia on
the 28th day after adjuvant injection. The blood samples
were collected in sterile tubes by cardiac puncture and
centrifuged. The serum IL-6 and TNF-a levels were
measured using ELISA kits specific for rat IL-6 and
TNF-a.
Histopathological Examination of Joints
Hind limbs were removed and immersed in 10% neutral
formalin solution overnight. The specimens were decalci-
fied in 10% EDTA solution for 3 weeks. After decalcifica-
tion, the specimens were dehydrated and embedded in
paraffin. Sections of 6mm were stained with hematoxylin
and eosin, and observed with a light microscope, evaluated
for synovitis, pannus formation and bone and/or cartilage
destruction based on a previously described scoring
system: grade 0, normal; grade 1, mild inflammation,
mild hyperplasia of the synovial lining layer, mild cartilage
destruction without bone erosion; grade 2–4, increasing
degrees of inflammatory cell infiltrates, synovial lining
212 Effect of Tibetan medicated-bath on arthritishyperplasia and pannus formation and cartilage and bone
destruction (10).
Some legs were processed for scanning electron micro-
scopy (SEM). Soft tissues were removed from the bones
by immersion in 0.5% papain solution at 37 C for
3 days. Residual debris was washed off using 5% sodium
hypochlorite. After washing with distilled water, the
specimens were dehydrated with ethanol and critical-
point dried, mounted on stubs and coated with gold/
palladium using an ion sputter. The distal epiphyses of
the fibula–tibia complex were examined with a Hitachi
S-3500N scanning electron microscope.
Statistics
All values are expressed as means standard errors.
Statistical analysis was done using StatView J-4.5
(Abacus Concepts). Significance of the results was
determined by analysis of variance (ANOVA) and
Fisher’s Protected Least Significant Difference test.
A P-value 50.05 was considered statistically significant.
Results
Evaluation of Body Weight and Arthritis Score
To evaluate the arthritic progression of adjuvant-induced
arthritis, body weight and the arthritis score were
exploited as apparent indicators of arthritis. It is known
that redness and swelling of the joints and body weight
loss usually appear at the onset of arthritis. We found
that while the body weight of control rats increased
steadily during the experimental period, the AA rats
showed significantly lowered body weight from day 12
after adjuvant injection (Fig. 1). From the 16th day after
adjuvant injection, the body weight of T and D groups
was significantly higher than that of AA and W groups
(Fig. 1). The redness and swelling of the joints appeared
around day 12 and peaked on day 24 after adjuvant
injection. The mean arthritis score of AA and W groups
began to increase around 12th day and reached 12 from
day 20 to 28 (Fig. 2). The arthritis score for the D group
was significantly lower than that of AA and W groups
after day 16. From day 20, the arthritis score of
the T group was significantly below that of AA and
W groups (Fig. 2).
IL-6 and TNF-a levels in Rat Serum
IL-6 and TNF-a levels in rat serum are shown in
Figs 3 and 4. The levels in the control animals were
11 and 14pgml
 1 while the serum IL-6 level increased to
36pgml
 1 and the serum TNF-a level rose to 72pg ml
 1
in the AA group. In the D group, the levels decreased to
those of the control. The serum levels of the T group
decreased by 28 and 24% (P50.05), in comparison with
the AA group (Figs 3 and 4).
Histopathological Examination of Joints
In the AA and W groups, LM revealed severe
hyperplasia of the synovial lining cells, many inflamma-
tory cells infiltrated into the synovial membranes,
accompanied by the destruction of articular cartilage
and bone. In D and T groups, mild to moderate
hyperplasia of the synovial lining cells and the infiltration
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Figure 1. Changes in body weight of rats. Normal control (closed
circles), adjuvant arthritis (open squares), adjuvant arthritis with water
bath (closed triangles), adjuvant arthritis with Tibetan medicated bath
(open circles), adjuvant arthritis with dexamethasone (closed squares).
Each point represents the mean SE.
*P50.05, significant difference
from the adjuvant arthritis group at the respective time.
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Figure 2. Changes in mean arthritis score of rats. Adjuvant arthritis
(open squares), adjuvant arthritis with water bath (closed triangles),
adjuvant arthritis with Tibetan medicated bath (open circles), adjuvant
arthritis with dexamethasone (closed squares). Each point represents the
mean SE.
*P50.05, significant difference from the adjuvant arthritis
group at the respective time.
eCAM 2009;6(2) 213of inflammatory cells into the synovial membranes were
observed, with no marked destruction of the articular
joint or bone erosion (Fig. 5). Compared with AA and
W groups, the inflammatory cells and the synovial lining
cells were reduced in D and T groups (Fig. 5). SEM
showed that the surfaces of the distal epiphyses of tibia
and fibula in the control rats were smooth. Rough
surfaces of the distal epiphyses of the tibia and fibula
indicated the occurrence of the bone destruction and
abnormal bone (osteophyte) formation were observed in
the synovia of the ankle joints of AA and W groups
(Fig. 6), while in D and T groups, there was little bone
destruction or osteophyte formation at the distal epi-
physes of the tibia and fibula (Fig. 6). Histopathological
evaluation demonstrated that dexamethasone or Tibetan
medicated-bath therapy resulted in statistically significant
reductions in synovitis, pannus and erosion scores in
AA rats (Fig. 7).
Discussion
We found that after adjuvant injection, the ankle joints
of both sides showed remarkable swelling, many
inflammatory cells infiltrated into the synovial mem-
branes, articular cartilage and bone were destroyed and
abnormal bone formation was evident. Serum IL-6 and
TNF-a levels increased significantly. In the water-bath
group, we did not find any significant change in the
arthritis. The Tibetan medicated-bath and dexamethasone
groups showed diminished swelling of ankle joints and
alleviation of the infiltration of inflammatory cells and
cartilage destruction, demonstrating that Tibetan
medicated-bath therapy was beneficial for AA rats and
could therefore be considered as a useful treatment
for arthritis.
Although the role of balneotherapy has been subject to
much debate, it has been applied to patients with various
rheumatic conditions since ancient times. Reports of
patients with active and widespread RA, treated at the
Dead Sea area with hot sulfur baths, mud packs or
combination of bath, showed statistically significant
improvements for a period of up to 3 months (11).
Another study showed that Dead Sea water was effective
in reducing objective and subjective parameters of RA
activity and severity (12). The mechanisms by which
immersion in spa water or mud pack therapy affect
inflammatory and non-inflammatory joint diseases are
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Figure 3. Changes of serum IL-6 level. Rats were divided into five
groups, control (C), adjuvant arthritis (AA), adjuvant arthritis with
water bath (W), adjuvant arthritis with Tibetan medicated bath (T),
adjuvant arthritis with dexamethasone (D), each having eight rats.
*Significant difference (P50.05) when compared with the adjuvant
arthritis group.
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Figure 4. Changes of serum TNF-a level. Rats were divided into five
groups, control (C), adjuvant arthritis (AA), adjuvant arthritis with
water bath (W), adjuvant arthritis with Tibetan medicated bath (T),
adjuvant arthritis with dexamethasone (D), each having eight rats.
*Significant difference (P50.05) when compared with the adjuvant
arthritis group.
214 Effect of Tibetan medicated-bath on arthritisnot fully understood. It has been shown that muscle-tone,
joint mobility and pain intensity are influenced by
hydromechanical and thermal stimuli. O’Hare et al. (7)
showed that 2h of immersion in spa water at a
temperature of 35 C could induce significant diuresis
and natriuresis in normal subjects, which may constitute
part of the scientific rationale for spa treatment for
various diseases. When analyzing rat spleen cellular
composition after water-bath of 36–37 C, Garunova
and Aminova (13) found that the number of plasma
cells increased in the structural components of the spleen,
which may indicate the activation of humoral immunity.
We, however, did not find any significant changes in
arthritis or serum cytokine levels after water-bath
treatment and propose that 40 C warm water-bath does
not improve arthritic symptoms.
Recent reports of mud-baths on rat AA have shown that
after mud-bath application improved arthritis and lowered
increased serum IL-1b and TNF-a levels. This result sug-
gests mud-baths have an anti-inflammatory effect on AA in
rats via the down-regulation of IL-1b and TNF-a (14).
Tibetan medicated-bath therapy has been known to
relieve symptoms of RA for centuries and is widely used
in Tibet. However, the reported scientific evidence for its
efficacy is poor and the pharmacological mechanism
remains unidentified. The main components of Tibetan
medicine are Rhododendron anthopogonoides Maxim.,
Myricaria germanica (L.) Desv., Artemisia sieversiana
Ehrhart ex Willd., Rhamnus parvifolia Bunge, Sabina
chinensis (L.) Antoine and Ephedra sinica. Almost all of
these plants are native to the Tibetan plateau. They grow
in a special environment, with low oxygen, strong
ultraviolet light and low temperatures and are considered
to be effective for RA. Clinical investigations have
reported that the rheumatoid factor titer of RA patients,
who underwent Tibetan medicated-bath, is markedly
lower. It was also demonstrated that Tibetan medi-
cated-bath had an immunomodulating effect on RA
patients through increasing CD8 cells and decreasing
CD4 cells (8). No reports have elucidated the action
mechanism of Tibetan medicated-bath therapy on
arthritis.
Figure 5. Representative light micrographs of rat ankle joints. Infiltration of many inflammatory cells and destruction of articular cartilages are
present in (A) adjuvant arthritis and (B) adjuvant arthritis with water-bath rats. No marked cartilage erosion is observed in (C) adjuvant arthritis
with Tibetan medicated bath and (D) adjuvant arthritis with dexamethasone rats. Bar¼0.1mm. Magnification,  100.
eCAM 2009;6(2) 215Figure 6. Representative scanning electron micrographs of rat distal epiphyses of tibia and fibula. Apparent bone destruction and osteophyte
formation are observed in (A) adjuvant arthritis and (B) adjuvant arthritis with water-bath rats. There is slight bone destruction or osteophyte
formation in (C) adjuvant arthritis with Tibetan medicated bath and (D) adjuvant arthritis with dexamethasone rats. Bar¼2mm. Magnification,  9.
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Figure 7. Quantitation of histopathological analysis of synovitis, pannus and erosion of bone and cartilage. Rats were divided into five groups,
control (C), adjuvant arthritis (AA), adjuvant arthritis with water bath (W), adjuvant arthritis with Tibetan medicated bath (T), adjuvant arthritis
with dexamethasone (D), each having eight rats.
*Significant difference (P50.05) when compared with the adjuvant arthritis group.
216 Effect of Tibetan medicated-bath on arthritisWe found that increased IL-6 and TNF-a levels in AA
rats significantly decreased after Tibetan medicated-bath
therapy, as seen in dexamethasone-treated animals.
Previous studies revealed key roles for inflammatory
cytokines, such as IL-6 and TNF-a, in the pathogenesis
of RA (15). Elevated levels of IL-6 and TNF-a were
found both in serum and synovial fluid of RA patients
(16). It has been suggested that those inflammatory
cytokines are produced through continuous activation
of T cells and interaction of activated T cells and
monocytes/macrophages in RA. Moreover, anti-IL-6 and
anti-TNF have been reported to be effective in the
treatment of RA (17). It is conceivable that IL-6 and
TNF-a possess an important function for arthritis at
the level of destroying joints at local inflammation sites
and we consider that IL-6 and TNF-a may play an
important part in the pharmacological mechanism of
Tibetan medicated-bath therapy for adjuvant arthritis.
Although IL-6 and TNF-a play a crucial role in the
pathogenesis of arthritis, the inhibition of pro-inflamma-
tory cytokines is probably only one of the complex action
mechanisms of balneotherapy and further study is needed
to clarify the action mechanism of Tibetan medicated-bath
therapy on articular inflammatory processes. Clinically,
controlled trials are mandatory to test the efficacy of
Tibetan medicated-bath therapy in RA patients.
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